Kai Lin Liu
Chief Investment Officer at Beijing Biostar Pharmaceuticals Co. Ltd.
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Li Tang | M | 61 |
Beijing Biostar Pharmaceuticals Co. Ltd.
 Beijing Biostar Pharmaceuticals Co. Ltd. Pharmaceuticals: MajorHealth Technology Beijing Biostar Pharmaceuticals Co. Ltd. engages in the tumor treatment. The company focuses on the development of new anti-cancer drugs with independent intellectual property rights. Its product Utidelone injection is the new-generation microtubule inhibitor produced by microbial fermentation process. The company was founded by Li Tang and Rong Guo Qiu on July 11, 2002 and is headquartered in Beijing, China. | 22 years |
| Rong Guo Qiu | M | 62 |
Beijing Biostar Pharmaceuticals Co. Ltd.
Beijing Biostar Pharmaceuticals Co. Ltd. Pharmaceuticals: MajorHealth Technology Beijing Biostar Pharmaceuticals Co. Ltd. engages in the tumor treatment. The company focuses on the development of new anti-cancer drugs with independent intellectual property rights. Its product Utidelone injection is the new-generation microtubule inhibitor produced by microbial fermentation process. The company was founded by Li Tang and Rong Guo Qiu on July 11, 2002 and is headquartered in Beijing, China. | 22 years |
| Heng Xie | M | 65 |
Beijing Biostar Pharmaceuticals Co. Ltd.
Beijing Biostar Pharmaceuticals Co. Ltd. Pharmaceuticals: MajorHealth Technology Beijing Biostar Pharmaceuticals Co. Ltd. engages in the tumor treatment. The company focuses on the development of new anti-cancer drugs with independent intellectual property rights. Its product Utidelone injection is the new-generation microtubule inhibitor produced by microbial fermentation process. The company was founded by Li Tang and Rong Guo Qiu on July 11, 2002 and is headquartered in Beijing, China. | 2 years |
| Quan Zhou | F | 38 |
Beijing Biostar Pharmaceuticals Co. Ltd.
Beijing Biostar Pharmaceuticals Co. Ltd. Pharmaceuticals: MajorHealth Technology Beijing Biostar Pharmaceuticals Co. Ltd. engages in the tumor treatment. The company focuses on the development of new anti-cancer drugs with independent intellectual property rights. Its product Utidelone injection is the new-generation microtubule inhibitor produced by microbial fermentation process. The company was founded by Li Tang and Rong Guo Qiu on July 11, 2002 and is headquartered in Beijing, China. | 15 years |
| Li Xin Wang | M | 54 |
Beijing Biostar Pharmaceuticals Co. Ltd.
Beijing Biostar Pharmaceuticals Co. Ltd. Pharmaceuticals: MajorHealth Technology Beijing Biostar Pharmaceuticals Co. Ltd. engages in the tumor treatment. The company focuses on the development of new anti-cancer drugs with independent intellectual property rights. Its product Utidelone injection is the new-generation microtubule inhibitor produced by microbial fermentation process. The company was founded by Li Tang and Rong Guo Qiu on July 11, 2002 and is headquartered in Beijing, China. | 3 years |
| Dong Ran | M | 38 |
Beijing Biostar Pharmaceuticals Co. Ltd.
Beijing Biostar Pharmaceuticals Co. Ltd. Pharmaceuticals: MajorHealth Technology Beijing Biostar Pharmaceuticals Co. Ltd. engages in the tumor treatment. The company focuses on the development of new anti-cancer drugs with independent intellectual property rights. Its product Utidelone injection is the new-generation microtubule inhibitor produced by microbial fermentation process. The company was founded by Li Tang and Rong Guo Qiu on July 11, 2002 and is headquartered in Beijing, China. | 1 years |
| Cheng Zhang | M | 49 |
Beijing Biostar Pharmaceuticals Co. Ltd.
Beijing Biostar Pharmaceuticals Co. Ltd. Pharmaceuticals: MajorHealth Technology Beijing Biostar Pharmaceuticals Co. Ltd. engages in the tumor treatment. The company focuses on the development of new anti-cancer drugs with independent intellectual property rights. Its product Utidelone injection is the new-generation microtubule inhibitor produced by microbial fermentation process. The company was founded by Li Tang and Rong Guo Qiu on July 11, 2002 and is headquartered in Beijing, China. | 6 years |
| Song Dong Meng | M | 54 |
Beijing Biostar Pharmaceuticals Co. Ltd.
Beijing Biostar Pharmaceuticals Co. Ltd. Pharmaceuticals: MajorHealth Technology Beijing Biostar Pharmaceuticals Co. Ltd. engages in the tumor treatment. The company focuses on the development of new anti-cancer drugs with independent intellectual property rights. Its product Utidelone injection is the new-generation microtubule inhibitor produced by microbial fermentation process. The company was founded by Li Tang and Rong Guo Qiu on July 11, 2002 and is headquartered in Beijing, China. | 2 years |
| Shu Feng Zhang | M | 55 |
Beijing Biostar Pharmaceuticals Co. Ltd.
Beijing Biostar Pharmaceuticals Co. Ltd. Pharmaceuticals: MajorHealth Technology Beijing Biostar Pharmaceuticals Co. Ltd. engages in the tumor treatment. The company focuses on the development of new anti-cancer drugs with independent intellectual property rights. Its product Utidelone injection is the new-generation microtubule inhibitor produced by microbial fermentation process. The company was founded by Li Tang and Rong Guo Qiu on July 11, 2002 and is headquartered in Beijing, China. | 8 years |
| Ri Xiang Kong | M | 47 |
Beijing Biostar Pharmaceuticals Co. Ltd.
Beijing Biostar Pharmaceuticals Co. Ltd. Pharmaceuticals: MajorHealth Technology Beijing Biostar Pharmaceuticals Co. Ltd. engages in the tumor treatment. The company focuses on the development of new anti-cancer drugs with independent intellectual property rights. Its product Utidelone injection is the new-generation microtubule inhibitor produced by microbial fermentation process. The company was founded by Li Tang and Rong Guo Qiu on July 11, 2002 and is headquartered in Beijing, China. | 21 years |
| Yu Li Zhang | M | 59 |
Nankai University
| 16 years |
| Yik Pun Chan | M | 42 |
Beijing Biostar Pharmaceuticals Co. Ltd.
Beijing Biostar Pharmaceuticals Co. Ltd. Pharmaceuticals: MajorHealth Technology Beijing Biostar Pharmaceuticals Co. Ltd. engages in the tumor treatment. The company focuses on the development of new anti-cancer drugs with independent intellectual property rights. Its product Utidelone injection is the new-generation microtubule inhibitor produced by microbial fermentation process. The company was founded by Li Tang and Rong Guo Qiu on July 11, 2002 and is headquartered in Beijing, China. | - |
| Pai Zhu | M | 31 |
Beijing Biostar Pharmaceuticals Co. Ltd.
Beijing Biostar Pharmaceuticals Co. Ltd. Pharmaceuticals: MajorHealth Technology Beijing Biostar Pharmaceuticals Co. Ltd. engages in the tumor treatment. The company focuses on the development of new anti-cancer drugs with independent intellectual property rights. Its product Utidelone injection is the new-generation microtubule inhibitor produced by microbial fermentation process. The company was founded by Li Tang and Rong Guo Qiu on July 11, 2002 and is headquartered in Beijing, China. | 3 years |
| Fei Peng | M | 50 |
Beijing Biostar Pharmaceuticals Co. Ltd.
Beijing Biostar Pharmaceuticals Co. Ltd. Pharmaceuticals: MajorHealth Technology Beijing Biostar Pharmaceuticals Co. Ltd. engages in the tumor treatment. The company focuses on the development of new anti-cancer drugs with independent intellectual property rights. Its product Utidelone injection is the new-generation microtubule inhibitor produced by microbial fermentation process. The company was founded by Li Tang and Rong Guo Qiu on July 11, 2002 and is headquartered in Beijing, China. | 2 years |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Wen Feng Shi | M | 46 |
Nankai University
| 4 years |
| Wen Quan Wang | M | 44 |
Nankai University
| 4 years |
| Yi Xin | F | 39 |
Nankai University
| 4 years |
| Yan Fang Xu | M | 56 |
Beijing Biostar Pharmaceuticals Co. Ltd.
Beijing Biostar Pharmaceuticals Co. Ltd. Pharmaceuticals: MajorHealth Technology Beijing Biostar Pharmaceuticals Co. Ltd. engages in the tumor treatment. The company focuses on the development of new anti-cancer drugs with independent intellectual property rights. Its product Utidelone injection is the new-generation microtubule inhibitor produced by microbial fermentation process. The company was founded by Li Tang and Rong Guo Qiu on July 11, 2002 and is headquartered in Beijing, China. | - |
| Li Guan | M | 47 |
Nankai University
| 2 years |
| Yong Sheng Zhao | M | 37 |
Nankai University
| 4 years |
| Ze Lin Zhang | M | 49 |
Nankai University
| 2 years |
| Ying Zhong Tan | M | 62 |
Nankai University
| 1 years |
| Ze Guang Li | M | 44 |
Nankai University
| 3 years |
| Yang Xu | M | 45 |
Nankai University
| 1 years |
| Wei Xie | M | 50 |
Nankai University
| 4 years |
| Rui Wang | F | 39 |
Nankai University
| 4 years |
| Ying JIe Li | M | 40 |
Nankai University
| 2 years |
| Ting Li | F | 35 |
Nankai University
| 4 years |
| Yu Peng Li | M | 41 |
Beijing Biostar Pharmaceuticals Co. Ltd.
Beijing Biostar Pharmaceuticals Co. Ltd. Pharmaceuticals: MajorHealth Technology Beijing Biostar Pharmaceuticals Co. Ltd. engages in the tumor treatment. The company focuses on the development of new anti-cancer drugs with independent intellectual property rights. Its product Utidelone injection is the new-generation microtubule inhibitor produced by microbial fermentation process. The company was founded by Li Tang and Rong Guo Qiu on July 11, 2002 and is headquartered in Beijing, China. | 3 years |
| Dong Hong Zhang | M | 49 |
Nankai University
| 3 years |
| Chang Ying Xu | M | 52 |
Nankai University
| 2 years |
| Lili Zhang | F | - |
Nankai University
| 4 years |
| Olivia Lingyun Zhang | F | - |
Nankai University
| 4 years |
| Chong Fu He | M | 46 |
Nankai University
| 2 years |
| Zhao Ning Li | M | 46 |
Nankai University
| 1 years |
| Zhong Bin Wang | M | 42 |
Nankai University
| 2 years |
| Dai Ping Chen | M | 41 |
Nankai University
| 4 years |
| Min Zeng | F | - |
Nankai University
| 1 years |
| Dong Xu Sun | M | 39 |
Nankai University
| 4 years |
| Ye Sheng | M | 50 |
Nankai University
| 4 years |
| Yu Qiang Zhang | M | 62 |
Nankai University
| 2 years |
| Yong Gang Gao | M | 59 |
Nankai University
| 3 years |
| Zhi Hua Zhang | M | 67 |
Nankai University
| 2 years |
| Bin Zhang | M | 45 |
Nankai University
| 3 years |
| Chang Hong Bai | M | 59 |
Nankai University
| 1 years |
| Fei Ming Liu | M | 55 |
Nankai University
| 3 years |
| Tian Hua Zhang | M | 60 |
Nankai University
| 2 years |
| Yong Liang Wang | M | 59 |
Nankai University
| 4 years |
| Zhen Hua Chen | M | - |
Nankai University
| 4 years |
| Xiang Peng Bo | M | 39 |
Nankai University
| 1 years |
| Xin Guang Yan | M | 50 |
Nankai University
| 1 years |
| Zhi Yong Wang | M | 52 |
Nankai University
| 1 years |
| Xiao Xuan Li | M | 50 |
Nankai University
| 2 years |
| Zou Ruiyang | M | 38 |
Nankai University
| 4 years |
| Wei Fang | M | 44 |
Nankai University
| 2 years |
| Ray Cao | M | - |
Nankai University
| 4 years |
| Ping Yan Bai | M | 52 |
Nankai University
| 2 years |
| Wei Hong Yang | M | 55 |
Nankai University
| 3 years |
| Shi Chen | M | 40 |
Nankai University
| 2 years |
| Simon Dazhong Lu | M | 55 |
Nankai University
| 3 years |
| Jia Chen | M | 43 |
Nankai University
| 4 years |
| Da Cheng | M | 47 |
Nankai University
| 4 years |
| Dong Xue Liu | M | 38 |
Nankai University
| 4 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| China | 63 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Kai Lin Liu
- Personal Network
